InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,652.00
(
0.06%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,876.52
(
0.13%
)
Post# of 1990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

blackcat

Send PM Follow Ignore
Followers 65
Posts 40044
Boards Moderated 2
Alias Born 07/08/2002

blackcat

Member Level

Re: Pip611 post# 136

Thursday, 07/28/2016 9:30:49 AM

Thursday, July 28, 2016 9:30:49 AM

Post# of 1990
Well, unfortunately, you're right.

Argos Therapeutics, Inc. (Nasdaq:ARGS) (“Argos”), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies for the treatment of cancer based on the Arcelis® technology platform, today announced the pricing of its public offering of 9,090,909 shares of its common stock and accompanying warrants to purchase up to an aggregate of 6,818,181 shares of its common stock at a price of $5.50 per share and accompanying warrant.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up